Kromatid logo

Kromatid Funding & Investors

Longmont, CO

KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents.

kromatid.com

Total Amount Raised: $20,105,556

Kromatid Funding Rounds

  • Series C

    $4,881,455

  • Series B

    $9,103,358

  • Series Unknown

    $2,000,000

    Series Unknown Investors

    BroadOak Capital Partners
  • Series A

    $1,925,000

  • Series A

    $2,145,743

    Series A Investors

    First Capital Ventures
  • Debt Financing

    $50,000

Funding info provided by Diffbot.